Literature DB >> 18485837

High temperature-ultra performance liquid chromatography-mass spectrometry for the metabonomic analysis of Zucker rat urine.

Helen G Gika1, Georgios Theodoridis, Jon Extance, Anthony M Edge, Ian D Wilson.   

Abstract

The applicability and potential of using elevated temperatures and sub 2-microm porous particles in chromatography for metabonomics/metabolomics was investigated using, for the first time, solvent temperatures higher than the boiling point of water (up to 180 degrees C) and thermal gradients to reduce the use of organic solvents. Ultra performance liquid chromatography, combined with mass spectrometry, was investigated for the global metabolite profiling of the plasma and urine of normal and Zucker (fa/fa) obese rats (a well established disease animal model). "Isobaric" high temperature chromatography, where the temperature and flow rate follow a gradient program, was developed and evaluated against a conventional organic solvent gradient. LC-MS data were first examined by established chromatographic criteria in order to evaluate the chromatographic performance and next were treated by special peak picking algorithms to allow the application of multivariate statistics. These studies showed that, for urine (but not plasma), chromatography at elevated temperatures provided better results than conventional reversed-phase LC with higher peak capacity and better peak asymmetry. From a systems biology point of view, better group clustering and separation was obtained with a larger number of variables of high importance when using high temperature-ultra performance liquid chromatography (HT-UPLC) compared to conventional solvent gradients.

Entities:  

Mesh:

Year:  2008        PMID: 18485837     DOI: 10.1016/j.jchromb.2008.04.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

Review 2.  Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.

Authors:  M F Hivert; W Perng; S M Watkins; C S Newgard; L C Kenny; B S Kristal; M E Patti; E Isganaitis; D L DeMeo; E Oken; M W Gillman
Journal:  J Dev Orig Health Dis       Date:  2015-01-29       Impact factor: 2.401

3.  Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS.

Authors:  Ling Hao; Xuefei Zhong; Tyler Greer; Hui Ye; Lingjun Li
Journal:  Analyst       Date:  2015-01-21       Impact factor: 4.616

4.  Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA).

Authors:  Marta Ugarte; Marie Brown; Katherine A Hollywood; Garth J Cooper; Paul N Bishop; Warwick B Dunn
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

5.  Chemical profiles and identification of key compound caffeine in marine-derived traditional Chinese medicine Ostreae concha.

Authors:  Xue Yang; Shi-Lu Zhou; Ai-Cui Ma; Hai-Tao Xu; Hua-Shi Guan; Hong-Bing Liu
Journal:  Mar Drugs       Date:  2012-05-23       Impact factor: 6.085

6.  Plasma metabolomic profiling of patients with diabetes-associated cognitive decline.

Authors:  Lin Zhang; Meng Li; Libin Zhan; Xiaoguang Lu; Lina Liang; Benli Su; Hua Sui; Zhengnan Gao; Yuzhong Li; Ying Liu; Benhui Wu; Qigui Liu
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.